14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Oct 10, 2023 Buy 600 000 Mcfarlane Neil F. Stock Option (right to buy)
Oct 10, 2023 Buy 200 000 Mcfarlane Neil F. Restricted Stock Unit
Oct 10, 2023 Buy 0 Mcfarlane Neil F.
Sep 06, 2023 Buy 1 000 Clifton R. Laduane Common Stock
Sep 06, 2023 Buy 10 000 Anderson Thomas Common Stock
Sep 05, 2023 Buy 500 Schafer Joshua Common Stock
Sep 05, 2023 Buy 10 000 Bode John B Common Stock
Aug 07, 2023 Buy 58 800 Anderson Thomas Stock Option (right to buy)
Aug 07, 2023 Buy 0 Anderson Thomas
Jun 23, 2023 Buy 275 Watton Corey Michael Common Stock
Jun 09, 2023 Buy 325 Watton Corey Michael Common Stock
May 31, 2023 Buy 10 000 Favorito Tamara A Stock Option (right to buy)
May 30, 2023 Buy 400 Watton Corey Michael Common Stock
May 19, 2023 Buy 1 000 Schafer Joshua Common Stock
May 18, 2023 Buy 2 451 Bode John B Common Stock
May 18, 2023 Buy 100 Bode John B Common Stock
May 18, 2023 Buy 4 759 Bode John B Common Stock
May 18, 2023 Buy 1 000 Bode John B Common Stock
May 18, 2023 Buy 300 Bode John B Common Stock
May 18, 2023 Buy 1 390 Bode John B Common Stock
May 18, 2023 Buy 689 Clifton R. Laduane Common Stock
May 18, 2023 Buy 2 000 Clifton R. Laduane Common Stock
May 18, 2023 Buy 51 Clifton R. Laduane Common Stock
May 03, 2023 Buy 58 800 Calder Douglas W Stock Option (right to buy)
May 03, 2023 Buy 58 800 Watton Corey Michael Stock Option (right to buy)
May 03, 2023 Buy 36 300 Dixon Wendy L Stock Option (right to buy)
May 03, 2023 Buy 58 800 Bode John B Stock Option (right to buy)
Apr 25, 2023 Buy 0 Calder Douglas W
Apr 25, 2023 Buy 39 200 Saluri Joseph Stock Option (right to buy)
Apr 25, 2023 Buy 49 200 Plooster Matthew R Stock Option (right to buy)
Apr 25, 2023 Buy 39 200 Favorito Tamara A Stock Option (right to buy)
Apr 25, 2023 Buy 22 500 Dixon Wendy L Stock Option (right to buy)
Apr 25, 2023 Buy 0 Watton Corey Michael
Apr 25, 2023 Buy 0 Dixon Wendy L
Apr 25, 2023 Buy 0 Bode John B
Mar 17, 2023 Buy 519 Seymour Tamara A Common Stock
Mar 14, 2023 Buy 2 000 Schafer Joshua Common Stock
Mar 10, 2023 Buy 100 Sangiovanni Timothy J. Common Stock
Mar 10, 2023 Buy 1 100 Sangiovanni Timothy J. Common Stock
Mar 10, 2023 Buy 1 725 Clifton R. Laduane Common Stock
Mar 09, 2023 Buy 11 000 Plooster Matthew R Common Stock
Mar 09, 2023 Buy 5 000 Tierney David S Common Stock
Mar 09, 2023 Buy 10 000 Pascoe Richard W Common Stock
Jan 13, 2023 Buy 25 Clifton R. Laduane Common Stock
Jan 13, 2023 Buy 610 Clifton R. Laduane Common Stock
Jan 13, 2023 Buy 9 500 Pascoe Richard W Common Stock
Jan 09, 2023 Buy 459 726 Clifton R. Laduane Stock Option (right to buy)
Jan 09, 2023 Buy 300 000 Mickle Christal M M Stock Option (right to buy)
Jan 09, 2023 Buy 306 000 Guenther Sven Stock Option (right to buy)
Jan 09, 2023 Buy 300 000 Schafer Joshua Stock Option (right to buy)
Jan 09, 2023 Buy 700 000 Pascoe Richard W Stock Option (right to buy)
Jan 09, 2023 Buy 136 986 Sangiovanni Timothy J. Stock Option (right to buy)
Jan 06, 2023 Buy 50 092 Mickle Christal M M Stock Option (right to buy)
Jan 06, 2023 Buy 0 Mickle Christal M M Common Stock
Jan 06, 2023 Buy 0 Mickle Christal M M Common Stock
Jan 06, 2023 Buy 0 Mickle Christal M M Common Stock
Jan 06, 2023 Buy 0 Mickle Christal M M Common Stock
Jan 06, 2023 Buy 0 Schafer Joshua
Jan 06, 2023 Buy 0 Schafer Joshua
Nov 28, 2022 Buy 22 500 Posner Christopher Stock Option (right to buy)
Sep 30, 2022 Buy 400 Clifton R. Laduane Common Stock
Sep 30, 2022 Buy 600 Clifton R. Laduane Common Stock
Jun 28, 2022 Buy 15 000 Tierney David S Stock Option (right to buy)
Jun 28, 2022 Buy 15 000 Tierney David S Stock Option (right to buy)
Jun 28, 2022 Buy 15 000 Saluri Joseph Stock Option (right to buy)
Jun 28, 2022 Buy 15 000 Plooster Matthew R Stock Option (right to buy)
Jun 28, 2022 Buy 15 000 Plooster Matthew R Stock Option (right to buy)
Jun 28, 2022 Buy 15 000 Seymour Tamara A Stock Option (right to buy)
May 25, 2022 Buy 2 000 Tierney David S Common Stock
May 25, 2022 Buy 1 000 Mickle Travis C Common Stock
May 25, 2022 Buy 2 000 Mickle Travis C Common Stock
May 25, 2022 Buy 10 000 Mickle Travis C Common Stock
May 20, 2022 Buy 200 Seymour Tamara A Common Stock
May 18, 2022 Buy 339 Plooster Matthew R Common Stock
May 18, 2022 Buy 3 051 Plooster Matthew R Common Stock
May 18, 2022 Buy 915 Plooster Matthew R Common Stock
May 18, 2022 Buy 695 Plooster Matthew R Common Stock
May 18, 2022 Buy 333 Pascoe Richard W Common Stock
May 18, 2022 Buy 1 700 Pascoe Richard W Common Stock
May 18, 2022 Buy 1 767 Pascoe Richard W Common Stock
May 18, 2022 Buy 400 Pascoe Richard W Common Stock
May 18, 2022 Buy 400 Pascoe Richard W Common Stock
May 18, 2022 Buy 100 Pascoe Richard W Common Stock
May 18, 2022 Buy 300 Pascoe Richard W Common Stock
May 18, 2022 Buy 1 200 Clifton R. Laduane Common Stock
Feb 01, 2022 Buy 50 092 Sangiovanni Timothy J. Stock Option (right to buy)
Feb 01, 2022 Buy 83 486 Guenther Sven Stock Option (right to buy)
Feb 01, 2022 Buy 83 486 Clifton R. Laduane Stock Option (right to buy)
Feb 01, 2022 Buy 127 286 Pascoe Richard W Stock Option (right to buy)
Feb 01, 2022 Buy 267 156 Mickle Travis C Stock Option (right to buy)
Dec 01, 2021 Buy 2 500 Plooster Matthew R Common Stock
Nov 30, 2021 Buy 1 500 Pascoe Richard W Common Stock
Nov 30, 2021 Buy 2 000 Tierney David S Common Stock
Nov 18, 2021 Buy 2 250 Mickle Travis C Common Stock
Nov 18, 2021 Buy 510 Clifton R. Laduane Common Stock
Nov 10, 2021 Buy 100 000 Pascoe Richard W Stock Option (right to buy)
Sep 29, 2021 Buy 215 Clifton R. Laduane Common Stock
Sep 20, 2021 Buy 935 Clifton R. Laduane Common Stock
Sep 01, 2021 Buy 230 Clifton R. Laduane Common Stock
Aug 30, 2021 Buy 5 000 Mickle Travis C Common Stock
INSIDER POWER
73.449
Last 100 transactions
Buy: 4 428 769 | Sell: 0 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 73.449.

In total, the insiders bought 4 428 769 and sold 0 KMPH shares in the last 100 trades.

Click to get the best stock tips daily for free!

About KemPharm

KemPharm KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focuse... KMPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT